{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:53:10Z","timestamp":1790949190126,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Health Commission of Henan Province","award":["LHGJ20210387"],"award-info":[{"award-number":["LHGJ20210387"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Glioma is a common tumor that occurs in the brain and spinal cord. Hypoxia is a crucial feature of the tumor microenvironment. Tumor-associated macrophages\/microglia play a crucial role in the advancement of glioma. This study aims to illuminate the detailed mechanisms by which hypoxia regulates microglia and, consequently, influences the progression of glioma.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The glioma cell viability and proliferation were analyzed by cell counting kit-8 assay and 5-ethynyl-2\u2019-deoxyuridine assay. Wound healing assay and transwell assay were implemented to detect glioma cell migration and invasion, respectively. Enzyme-linked immunosorbent assay was conducted to detect protein levels in cell culture medium. The protein levels in glioma cells and tumor tissues were evaluated using western blot analysis. The histological morphology of tumor tissue was determined by hematoxylin-eosin staining. The protein expression in tumor tissues was determined using immunohistochemistry. Human glioma xenograft in nude mice was employed to test the influence of hypoxic microglia-derived interleukin-1beta (IL-1\u03b2) and heparanase (HPSE) on glioma growth in vivo.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Hypoxic HMC3 cells promoted proliferation, migration, and invasion abilities of U251 and U87 cells by secreting IL-1\u03b2, which was upregulated by hypoxia-induced activation of hypoxia inducible factor-1alpha (HIF-1\u03b1). Besides, IL-1\u03b2 from HMC3 cells promoted glioma progression and caused activation of nuclear factor-\u03baB (NF-\u03baB) and upregulation of HPSE in vivo. We also confirmed that IL-1\u03b2 facilitated HPSE expression in U251 and U87 cells by activating NF-\u03baB. Hypoxic HMC3 cells-secreted IL-1\u03b2 facilitated the proliferation, migration, and invasion of U251 and U87 cells via NF-\u03baB-mediated upregulation of HPSE expression. Finally, we revealed that silencing HPSE curbed the proliferation and metastasis of glioma in mice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Hypoxia-induced activation of HIF-1\u03b1\/IL-1\u03b2 axis in microglia promoted glioma progression via NF-\u03baB-mediated upregulation of HPSE expression.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13062-024-00487-w","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T07:02:37Z","timestamp":1718089357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Hypoxia-induced activation of HIF-1alpha\/IL-1beta axis in microglia promotes glioma progression via NF-\u03baB-mediated upregulation of heparanase expression"],"prefix":"10.1186","volume":"19","author":[{"given":"Jinchao","family":"Si","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingya","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyu","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanwu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,11]]},"reference":[{"key":"487_CR1","doi-asserted-by":"crossref","unstructured":"Fangusaro J, Jones DT, Packer RJ, Gutmann DH, Milde T. Pediatric low-grade glioma: state-of-the-art and ongoing challenges. 2024; 26(1):25\u201337.","DOI":"10.1093\/neuonc\/noad195"},{"issue":"7","key":"487_CR2","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/jama.2023.0023","volume":"329","author":"LR Schaff","year":"2023","unstructured":"Schaff LR, Mellinghoff IK. Glioblastoma and other primary brain malignancies in adults: a review. JAMA. 2023;329(7):574\u201387.","journal-title":"JAMA"},{"key":"487_CR3","doi-asserted-by":"crossref","unstructured":"Wang GM, Cioffi G, Patil N. Importance of the intersection of age and sex to understand variation in incidence and survival for primary malignant gliomas. 2022; 24(2):302\u201310.","DOI":"10.1093\/neuonc\/noab199"},{"key":"487_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.semcancer.2017.11.010","volume":"51","author":"O Gusyatiner","year":"2018","unstructured":"Gusyatiner O, Hegi ME. Glioma epigenetics: from subclassification to novel treatment options. Semin Cancer Biol. 2018;51:50\u20138.","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"487_CR5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1158\/2159-8290.CD-20-1474","volume":"11","author":"JG Nicholson","year":"2021","unstructured":"Nicholson JG, Fine HA. Diffuse glioma heterogeneity and its therapeutic implications. Cancer Discov. 2021;11(3):575\u201390.","journal-title":"Cancer Discov"},{"issue":"3","key":"487_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s11060-020-03499-4","volume":"151","author":"CJ Przybylowski","year":"2021","unstructured":"Przybylowski CJ, Hervey-Jumper SL, Sanai N. Surgical strategy for insular glioma. J Neurooncol. 2021;151(3):491\u20137.","journal-title":"J Neurooncol"},{"issue":"4","key":"487_CR7","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3897\/folmed..e64431","volume":"64","author":"G Sioutas","year":"2022","unstructured":"Sioutas G, Nikova A, Birbilis T. Risk factors for pediatric glioma. Folia Med (Plovdiv). 2022;64(4):566\u201371.","journal-title":"Folia Med (Plovdiv)"},{"issue":"10","key":"487_CR8","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.3390\/cancers14102412","volume":"14","author":"S Grochans","year":"2022","unstructured":"Grochans S, Cybulska AM. Epidemiology of Glioblastoma Multiforme-Literature Review. Cancers. 2022;14(10):2412.","journal-title":"Cancers"},{"issue":"2","key":"487_CR9","doi-asserted-by":"publisher","first-page":"665","DOI":"10.7150\/thno.41692","volume":"11","author":"NH Boyd","year":"2021","unstructured":"Boyd NH, Tran AN, Bernstock JD, Etminan T, Jones AB, Gillespie GY, Friedman GK, Hjelmeland AB. Glioma stem cells and their roles within the hypoxic tumor microenvironment. Theranostics. 2021;11(2):665\u201383.","journal-title":"Theranostics"},{"issue":"1","key":"487_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10555-021-09997-9","volume":"41","author":"L Barthel","year":"2022","unstructured":"Barthel L, Hadamitzky M, Dammann P, Schedlowski M, Sure U, Thakur BK, Hetze S. Glioma: molecular signature and crossroads with tumor microenvironment. Cancer Metastasis Rev. 2022;41(1):53\u201375.","journal-title":"Cancer Metastasis Rev"},{"issue":"6","key":"487_CR11","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s00259-019-04621-z","volume":"47","author":"M Hu","year":"2020","unstructured":"Hu M, Zhu Y, Mu D, Fan B, Zhao S, Yang G, Ma L, Zheng J, Yu J. Correlation of hypoxia as measured by fluorine-18 fluoroerythronitroimidazole ((18)F-FETNIM) PET\/CT and overall survival in glioma patients. Eur J Nucl Med Mol Imaging. 2020;47(6):1427\u201334.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"487_CR12","doi-asserted-by":"publisher","first-page":"e109187","DOI":"10.15252\/embj.2021109187","volume":"41","author":"A Zhang","year":"2022","unstructured":"Zhang A, Huang Z, Tao W, Zhai K, Wu Q, Rich JN, Zhou W. USP33 deubiquitinates and stabilizes HIF-2alpha to promote hypoxia response in glioma stem cells. EMBO J. 2022;41(7):e109187.","journal-title":"EMBO J"},{"issue":"5","key":"487_CR13","first-page":"872","volume":"26","author":"D Liu","year":"2024","unstructured":"Liu D, Zhu H, Cheng L, Li R, Ma X, Wang J, Wang J, Zhang S, Li Y, Shu K, et al. Hypoxia-induced galectin-8 maintains stemness in glioma stem cells via autophagy regulation. Neurooncology. 2024;26(5):872\u201388.","journal-title":"Neurooncology"},{"issue":"1","key":"487_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13045-021-01102-5","volume":"14","author":"XC Ding","year":"2021","unstructured":"Ding XC, Wang LL, Zhang XD, Xu JL, Li PF, Liang H, Zhang XB, Xie L, Zhou ZH, Yang J, et al. The relationship between expression of PD-L1 and HIF-1alpha in glioma cells under hypoxia. J Hematol Oncol. 2021;14(1):92.","journal-title":"J Hematol Oncol"},{"key":"487_CR15","doi-asserted-by":"crossref","unstructured":"Sun S, Guo C, Gao T, Ma D, Su X, Pang Q, Zhang R. Hypoxia Enhances Glioma Resistance to Sulfasalazine-Induced Ferroptosis by Upregulating SLC7A11 via PI3K\/AKT\/HIF-1alpha Axis. Oxid Med Cell Longev 2022; 2022:7862430.","DOI":"10.1155\/2022\/7862430"},{"issue":"1","key":"487_CR16","doi-asserted-by":"publisher","first-page":"112547","DOI":"10.1016\/j.yexcr.2021.112547","volume":"402","author":"L Cheng","year":"2021","unstructured":"Cheng L, Peng R, Guo P, Zhang H, Liu D, Liao X, Liu Y, Mo X, Liao Y. A HIF1A\/miR-485-5p\/SRPK1 axis modulates the aggressiveness of glioma cells upon hypoxia. Exp Cell Res. 2021;402(1):112547.","journal-title":"Exp Cell Res"},{"key":"487_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathmechdis-051122-110348","volume":"19","author":"MA Jayaram","year":"2024","unstructured":"Jayaram MA, Phillips JJ. Role of the Microenvironment in Glioma Pathogenesis. Annu Rev Pathol. 2024;19:181\u2013201.","journal-title":"Annu Rev Pathol"},{"issue":"12","key":"487_CR18","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/j.cell.2022.04.038","volume":"185","author":"FS Varn","year":"2022","unstructured":"Varn FS, Johnson KC, Martinek J, Huse JT, Nasrallah MP, Wesseling P, Cooper LAD, Malta TM, Wade TE, Sabedot TS, et al. Glioma progression is shaped by genetic evolution and microenvironment interactions. Cell. 2022;185(12):2184\u2013e21992116.","journal-title":"Cell"},{"key":"487_CR19","doi-asserted-by":"publisher","first-page":"964898","DOI":"10.3389\/fimmu.2022.964898","volume":"13","author":"G Wang","year":"2022","unstructured":"Wang G, Zhong K, Wang Z, Zhang Z, Tang X, Tong A, Zhou L. Tumor-associated microglia and macrophages in glioblastoma: from basic insights to therapeutic opportunities. Front Immunol. 2022;13:964898.","journal-title":"Front Immunol"},{"key":"487_CR20","doi-asserted-by":"crossref","unstructured":"Tamai S, Ichinose T, Tsutsui T, Tanaka S, Garaeva F, Sabit H, Nakada M. Tumor Microenvironment in Glioma Invasion. Brain Sci 2022; 12(4).","DOI":"10.3390\/brainsci12040505"},{"issue":"6","key":"487_CR21","doi-asserted-by":"publisher","first-page":"e5947","DOI":"10.1371\/journal.pone.0005947","volume":"4","author":"A Murat","year":"2009","unstructured":"Murat A, Migliavacca E, Hussain SF, Heimberger AB, Desbaillets I, Hamou MF, Ruegg C, Stupp R, Delorenzi M, Hegi ME. Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia. PLoS ONE. 2009;4(6):e5947.","journal-title":"PLoS ONE"},{"key":"487_CR22","doi-asserted-by":"crossref","unstructured":"Petterson SA, S\u00f8rensen MD. Differential expression of checkpoint markers in the normoxic and hypoxic microenvironment of glioblastomas. 2023; 33(1):e13111.","DOI":"10.1111\/bpa.13111"},{"key":"487_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.freeradbiomed.2023.06.027","volume":"207","author":"HC Tsai","year":"2023","unstructured":"Tsai HC, Tong ZJ, Hwang TL, Wei KC, Chen PY, Huang CY, Chen KT, Lin YJ, Cheng HW, Wang HT. Acrolein produced by glioma cells under hypoxia inhibits neutrophil AKT activity and suppresses anti-tumoral activities. Free Radic Biol Med. 2023;207:17\u201328.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"487_CR24","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1002\/med.21771","volume":"41","author":"L You","year":"2021","unstructured":"You L, Wu W, Wang X, Fang L, Adam V, Nepovimova E, Wu Q, Kuca K. The role of hypoxia-inducible factor 1 in tumor immune evasion. Med Res Rev. 2021;41(3):1622\u201343.","journal-title":"Med Res Rev"},{"issue":"3","key":"487_CR25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11060-005-9103-z","volume":"78","author":"RL Jensen","year":"2006","unstructured":"Jensen RL, Ragel BT, Whang K, Gillespie D. Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas. J Neurooncol. 2006;78(3):233\u201347.","journal-title":"J Neurooncol"},{"key":"487_CR26","doi-asserted-by":"crossref","unstructured":"Infantino V, Santarsiero A, Convertini P, Todisco S, Iacobazzi V. Cancer Cell Metabolism in Hypoxia: role of HIF-1 as Key Regulator and Therapeutic Target. Int J Mol Sci 2021; 22(11).","DOI":"10.3390\/ijms22115703"},{"issue":"2","key":"487_CR27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10456-018-9600-2","volume":"21","author":"M Serocki","year":"2018","unstructured":"Serocki M, Bartoszewska S, Janaszak-Jasiecka A, Ochocka RJ, Collawn JF, Bartoszewski R. miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target. Angiogenesis. 2018;21(2):183\u2013202.","journal-title":"Angiogenesis"},{"issue":"4","key":"487_CR28","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1158\/1078-0432.CCR-20-2500","volume":"27","author":"L Nayak","year":"2021","unstructured":"Nayak L, Molinaro AM, Peters K, Clarke JL, Jordan JT, de Groot J, Nghiemphu L, Kaley T, Colman H, McCluskey C, et al. Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab alone for patients with recurrent glioblastoma. Clin Cancer Res. 2021;27(4):1048\u201357.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"487_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC, Ashley DM, Lopez GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: state of the art and future directions. CA Cancer J Clin. 2020;70(4):299\u2013312.","journal-title":"CA Cancer J Clin"},{"issue":"21","key":"487_CR30","first-page":"6480","volume":"25","author":"T Zhang","year":"2021","unstructured":"Zhang T, Xin Q, Kang JM. Bevacizumab for recurrent glioblastoma: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2021;25(21):6480\u201391.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"487_CR31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.canlet.2021.02.019","volume":"506","author":"C Arienti","year":"2021","unstructured":"Arienti C, Pignatta S, Zanoni M, Zamagni A, Cortesi M, Sarnelli A, Romeo A, Arpa D, Longobardi P, Bartolini D, et al. High-pressure oxygen rewires glucose metabolism of patient-derived glioblastoma cells and fuels inflammasome response. Cancer Lett. 2021;506:152\u201366.","journal-title":"Cancer Lett"},{"key":"487_CR32","doi-asserted-by":"publisher","first-page":"914236","DOI":"10.3389\/fimmu.2022.914236","volume":"13","author":"Y Xiao","year":"2022","unstructured":"Xiao Y, Wang Z, Zhao M, Deng Y, Yang M, Su G, Yang K, Qian C, Hu X, Liu Y, et al. Single-cell transcriptomics revealed subtype-specific Tumor Immune Microenvironments in Human glioblastomas. Front Immunol. 2022;13:914236.","journal-title":"Front Immunol"},{"issue":"4","key":"487_CR33","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/jnc.15097","volume":"156","author":"RF Amaral","year":"2021","unstructured":"Amaral RF, Geraldo LHM, Einicker-Lamas M, TCLS ES, Mendes F, Lima FRS. Microglial lysophosphatidic acid promotes glioblastoma proliferation and migration via LPA(1) receptor. J Neurochem. 2021;156(4):499\u2013512.","journal-title":"J Neurochem"},{"issue":"1","key":"487_CR34","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s13577-021-00619-8","volume":"35","author":"K Kai","year":"2022","unstructured":"Kai K, Komohara Y, Esumi S, Fujiwara Y, Yamamoto T, Uekawa K, Ohta K, Takezaki T, Kuroda J, Shinojima N, et al. Macrophage\/microglia-derived IL-1beta induces glioblastoma growth via the STAT3\/NF-kappaB pathway. Hum Cell. 2022;35(1):226\u201337.","journal-title":"Hum Cell"},{"issue":"9","key":"487_CR35","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1111\/cas.14984","volume":"112","author":"J Si","year":"2021","unstructured":"Si J, Li W, Li X, Cao L, Chen Z, Jiang Z. Heparanase confers temozolomide resistance by regulation of exosome secretion and circular RNA composition in glioma. Cancer Sci. 2021;112(9):3491\u2013506.","journal-title":"Cancer Sci"},{"issue":"1","key":"487_CR36","first-page":"255","volume":"23","author":"W Wu","year":"2010","unstructured":"Wu W, Pan C, Meng K, Zhao L, Du L, Liu Q, Lin R. Hypoxia activates heparanase expression in an NF-kappaB dependent manner. Oncol Rep. 2010;23(1):255\u201361.","journal-title":"Oncol Rep"},{"key":"487_CR37","doi-asserted-by":"publisher","first-page":"6985","DOI":"10.1038\/ncomms7985","volume":"6","author":"SR Hadigal","year":"2015","unstructured":"Hadigal SR, Agelidis AM, Karasneh GA, Antoine TE, Yakoub AM, Ramani VC, Djalilian AR, Sanderson RD, Shukla D. Heparanase is a host enzyme required for herpes simplex virus-1 release from cells. Nat Commun. 2015;6:6985.","journal-title":"Nat Commun"},{"issue":"1","key":"487_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.canlet.2015.02.043","volume":"361","author":"NB Hao","year":"2015","unstructured":"Hao NB, Tang B, Wang GZ, Xie R, Hu CJ, Wang SM, Wu YY, Liu E, Xie X, Yang SM. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K\/Akt\/NF-kappaB signaling pathway for gastric cancer metastasis. Cancer Lett. 2015;361(1):57\u201366.","journal-title":"Cancer Lett"},{"key":"487_CR39","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.matbio.2016.03.006","volume":"55","author":"VC Ramani","year":"2016","unstructured":"Ramani VC, Vlodavsky I, Ng M, Zhang Y, Barbieri P, Noseda A, Sanderson RD. Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotype. Matrix Biol. 2016;55:22\u201334.","journal-title":"Matrix Biol"},{"key":"487_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.mce.2017.05.004","volume":"470","author":"X An","year":"2018","unstructured":"An X, Zhang L, Yao Q, Li L, Wang B, Zhang J, He M, Zhang J. The receptor for advanced glycation endproducts mediates podocyte heparanase expression through NF-kappaB signaling pathway. Mol Cell Endocrinol. 2018;470:14\u201325.","journal-title":"Mol Cell Endocrinol"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-024-00487-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-024-00487-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-024-00487-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T07:06:58Z","timestamp":1718089618000},"score":1,"resource":{"primary":{"URL":"https:\/\/biologydirect.biomedcentral.com\/articles\/10.1186\/s13062-024-00487-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,11]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["487"],"URL":"https:\/\/doi.org\/10.1186\/s13062-024-00487-w","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,11]]},"assertion":[{"value":"31 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were reviewed and authorized by the Ethics Committee of the Second Affiliated Hospital of Zhengzhou University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The publication has been approved by all co-authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}